- Home
- FOXF vs RCKT Comparison
FOXF vs RCKT Comparison
Compare FOXF & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXF
- RCKT
- Stock Information
- Founded
- FOXF 2007
- RCKT 1999
- Country
- FOXF United States
- RCKT United States
- Employees
- FOXF N/A
- RCKT N/A
- Industry
- FOXF Motor Vehicles
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- FOXF Consumer Discretionary
- RCKT Health Care
- Exchange
- FOXF Nasdaq
- RCKT Nasdaq
- Market Cap
- FOXF 581.5M
- RCKT 340.9M
- IPO Year
- FOXF N/A
- RCKT N/A
- Fundamental
- Price
- FOXF $14.75
- RCKT $3.07
- Analyst Decision
- FOXF Strong Buy
- RCKT Buy
- Analyst Count
- FOXF 5
- RCKT 14
- Target Price
- FOXF $33.00
- RCKT $29.12
- AVG Volume (30 Days)
- FOXF 1.2M
- RCKT 2.1M
- Earning Date
- FOXF 11-06-2025
- RCKT 11-06-2025
- Dividend Yield
- FOXF N/A
- RCKT N/A
- EPS Growth
- FOXF N/A
- RCKT N/A
- EPS
- FOXF N/A
- RCKT N/A
- Revenue
- FOXF $1,459,086,000.00
- RCKT N/A
- Revenue This Year
- FOXF $8.61
- RCKT N/A
- Revenue Next Year
- FOXF $5.55
- RCKT $3,582.16
- P/E Ratio
- FOXF N/A
- RCKT N/A
- Revenue Growth
- FOXF 6.22
- RCKT N/A
- 52 Week Low
- FOXF $13.08
- RCKT $2.19
- 52 Week High
- FOXF $34.80
- RCKT $15.01
- Technical
- Relative Strength Index (RSI)
- FOXF 32.34
- RCKT 44.88
- Support Level
- FOXF $13.12
- RCKT $2.81
- Resistance Level
- FOXF $14.39
- RCKT $3.07
- Average True Range (ATR)
- FOXF 0.89
- RCKT 0.17
- MACD
- FOXF -0.02
- RCKT -0.02
- Stochastic Oscillator
- FOXF 15.76
- RCKT 55.50
About FOXF Fox Factory Holding Corp.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.